ZYZheng Yao

Zheng Yao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zheng Yao has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Hongjie Yang

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    5 shared publications
  • Xiaoli He

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    4 shared publications
  • Jiawen You

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    3 shared publications
  • Jiayuan Cai

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    3 shared publications
  • Yanming He

    Department of Endocrinology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, China

    3 shared publications
  • Yunyi Yang

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

    3 shared publications

Latest Publications

  • Association between immune-inflammatory biomarkers (NLR, PLR, SII, SIRI) and obesity in adults: a systematic review and meta-analysis

    by Yunyi Yang, Jingxiao Wang, Jiayuan Cai, Xiaoli He, Ningwei Wang, Min Zheng, Jiawen You, Zheng Yao, Hongjie Yang, Yanming He

    Background Obesity is regarded as a chronic, low-grade systemic inflammatory condition. However, whether immune–inflammatory indices derived from routine peripheral blood tests—including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI)—can accurately reflect obesity-associated inflammation remains controversial, as existing studies have reported inconsistent findings. Comparing these indices between people with obesity and people without obesity, and further evaluating sources of heterogeneity and their potential clinical implications, is of considerable significance for clarifying their role in obesity research and clinical application. Methods Relevant studies published up to September 30, 2025, were systematically searched in PubMed, EMBASE, the Cochrane Library, and Web of Science databases. A meta-analysis was conducted using standardized mean differences (SMDs) to evaluate overall effects, with additional subgroup and sensitivity analyses performed (PROSPERO registration number: CRD420251247523). Results A total of 30 studies were included, comprising 94,408 people with obesity and 129,927 people without obesity as controls. The meta-analysis demonstrated that NLR (SMD = 0.46, 95% CI: 0.10–0.82, p < 0.001), SII (SMD = 2.45, 95% CI: 0.89– 4.01, p < 0.001), and SIRI (SMD = 0.84, 95% CI: 0.47–1.22, p < 0.001) were significantly higher in the group of people with obesity compared with controls, whereas PLR showed no statistically significant difference (SMD = 0.00, 95% CI: −0.08–0.09, p > 0.05). Subgroup analyses indicated that these associations were more prominent in studies defining obesity by BMI, among individuals with chronic comorbidities, and within Asian and American populations. Conclusion NLR, SII, and SIRI may serve as potential low-cost biomarkers reflecting systemic inflammation associated with obesity, while PLR appears to have limited applicability. Future high-quality prospective studies are needed to validate their clinical utility in obesity risk stratification, prediction of complications, and monitoring of therapeutic responses, as well as to explore the potential value of combining these indices with traditional inflammatory and metabolic biomarkers.


  • Open Access

    Efficacy of selected dietary supplements and pharmacological agents on metabolic and oxidative stress outcomes in metabolic dysfunction–associated fatty liver disease (MAFLD): a Bayesian network meta-analysis

    by Yunyi Yang, Xiaoli He, Jiayuan Cai, Xiaoxiao Qu, Shufa Tan, Jiawen You, Yanming He, Zheng Yao, Hongjie Yang

    Objective: This study aimed to compare the relative efficacy of dietary supplements and pharmacological agents in improving metabolic and oxidative stress outcomes in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) through a systematic review and Bayesian network meta-analysis. Methods: PubMed, Embase, the Cochrane Library, and Web of Science databases were systematically searched to identify randomized controlled trials (RCTs) published between 1 January 2014, and 3 March 2024, that evaluated the effects of dietary supplements or pharmacological agents on MAFLD. Results: A total of 106 RCTs involving 7,273 participants were included, involving a variety of nutritional and pharmacological interventions. Pharmacological intervention plus bioactive regulator was the most effective in reducing triglycerides (TG) and low-density lipoprotein cholesterol (LDL-C). Nutrient plus pharmacological intervention was the most efficacious in improving glycated hemoglobin (HbA1c) and insulin levels. Pharmacological intervention plus another pharmacological intervention was most effective in reducing alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Phytochemicals significantly reduced interleukin-6 (IL-6), while bioactive metabolic regulators markedly decreased tumor necrosis factor-α (TNF-α). Herbal extracts demonstrated superior effects in enhancing total antioxidant capacity (TAC) and superoxide dismutase (SOD), while oleoylethanolamide (OEA) improved antioxidant enzyme activity and reduced malondialdehyde (MDA) levels. Further analysis revealed that garlic exerted the strongest effect in improving overall antioxidant capacity, whereas L-carnitine showed the most significant efficacy in suppressing lipid peroxidation. Conclusion: Multicomponent or mechanistically complementary interventions exhibited more stable potential benefits in improving glucose and lipid metabolism. Bioactive metabolic regulators (L-carnitine), endogenous lipid regulators (OEA), and herbal extracts (garlic) all demonstrated strong efficacy in enhancing antioxidant defense and alleviating oxidative damage. Further high-quality RCTs are needed to confirm these findings. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD42024555065.


  • Open Access

    Association between monocyte-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease and hepatic steatosis: evidence from NHANES 2017–2020

    by Yunyi Yang, Weijin Huang, Xiaoli He, Xiaoxiao Qu, Jiayuan Cai, Fengzhu Zhou, Ningwei Wang, Jiawen You, Xinyi Fu, Yanming He, et al.

    Original Article Association between monocyte-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease and hepatic steatosis: evidence from NHANES 2017–2020 Yunyi Yang, Weijin Huang, Xiaoli He, Xiaoxiao Qu, Jiayuan Cai, Fengzhu Zhou, Ningwei Wang, Jiawen You, Xinyi Fu, Yanming He, Zheng Yao, Hongjie Yang


  • Open Access

    Analysis of the Association Between TG/HDL, TyG, TyG-BMI, and ZJU Indices with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes

    by Yunyi Yang, Hongping Wang, Yanming He, Xiaoli He, Zheng Yao, Hongjie Yang

    Background: TG/HDL, TyG, TyG-BMI, and ZJU indices are associated with metabolic syndrome and cardiovascular diseases. This study aims to evaluate the relationships between these indices and metabolic dysfunction-associated fatty liver disease (MAFLD) in patients with type 2 diabetes (T2DM). Methods: We analyzed 598 T2DM patients, with MAFLD diagnosed based on abdominal ultrasound and clinical manifestations. Clinical characteristics and laboratory results were collected. Correlation analysis assessed the relationship between insulin resistance (IR) indicators and MAFLD. Logistic regression and restrictive cubic spline (RCS) analyses were performed to evaluate associations, and ROC curve analysis identified the most effective IR indicator for MAFLD. Results: Among the IR indices, the strongest association with MAFLD was observed for TyG-BMI (p < 0.001). Logistic regression analysis indicated a significant relationship between TyG-BMI and the diagnosis of MAFLD (P = 0.006). RCS curve analysis showed distinct trends: TG/HDL-C (J-shaped), TyG (inverted U-shaped), and TyG-BMI (linear), with TyG-BMI showing the most robust relationship. ROC curve analysis identified TyG-BMI as the most effective diagnostic indicator. Subgroup analysis revealed that TG/HDL, TyG, and the ZJU index had stronger effects in females, with TG/HDL being the most effective. Conclusion: TyG-BMI is a significant determinant for the diagnosis of MAFLD in T2DM patients, while TG/HDL is more effective for screening in female patients.